Secant Medical Receives Frost & Sullivan 2012 Enabling Technology Award Industry Analyst Distinguishes Medical Implantable Textile Structures Design Approach
PERKASIE, Pa.--(BUSINESS WIRE)--Secant Medical® announced today that it has received industry analyst Frost & Sullivan’s 2012 North American Enabling Technology Award for its medical implantable textile structures design approach.
“This award recognizes Secant Medical’s commitment to creating the enabling technologies that make possible therapeutic advances. We are honored by this recognition, as we continue to develop innovations that will further address the unmet medical needs of patients worldwide.”
“Implantable biomedical textiles constitute a dynamic research field characterized and challenged by the evolving needs of today's range of medical applications. Secant Medical's core expertise in materials science and deep understanding of biomedical textiles coupled with their interdisciplinary talent pool trained in fields such as biomedical and textile design engineering, among others, have ideally placed them as a successful solution provider where such converging technologies meet,” said Saju John Mathew, Frost & Sullivan technical insights industry analyst.
The Frost & Sullivan report noted, “Secant Medical is one of few suppliers that can provide customized design solutions at competitive prices to medical device manufacturers and notable clients in the biomedical device industry, enabling manufacturers to develop a portfolio of more innovative, effective and commercially successful medical device designs. The firm’s greatest asset lies in working toward the device manufacturer’s needs as a forward-thinking supplier in a constantly evolving industry.”
Commenting on the award, Erik Nadeau, president, Secant Medical said, “This award recognizes Secant Medical’s commitment to creating the enabling technologies that make possible therapeutic advances. We are honored by this recognition, as we continue to develop innovations that will further address the unmet medical needs of patients worldwide.”
“The Frost & Sullivan award confirms our dedication to design and engineering excellence through close collaboration with our clients,” added Jeffrey M. Koslosky, vice president, advanced technologies at Secant Medical.
Nadeau concluded, “I would like to thank Secant Medical’s employees, partners and clients for their role in enabling innovation in device design. They have made this award possible.”
About Secant Medical:
Secant Medical® is the leader in custom-developed biomedical textile structures for medical devices, helping clients meet challenges to bring device solutions to market quickly and effectively. Using constantly evolving advanced metallic and polymeric biomaterials, the company designs the high-performance textile structures that client innovations require in developing advanced orthopedic, cardiovascular, tissue-engineered, neurovascular and general surgery devices. Secant Medical is a business unit of Prodesco, Inc., part of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, contact Joannie Anthony at 215-257-8680 x1199 or email@example.com, or visit www.secantmedical.com/release-entry.php.